CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 13 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,155 | -42.4% | 5,586 | 0.0% | 0.00% | – |
| Q4 2019 | $3,743 | +69.0% | 5,586 | 0.0% | 0.00% | – |
| Q3 2019 | $2,215 | -26.6% | 5,586 | 0.0% | 0.00% | – |
| Q2 2019 | $3,019 | -42.2% | 5,586 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $5,223 | +54.5% | 5,586 | 0.0% | 0.00% | – |
| Q4 2018 | $3,380 | -55.8% | 5,586 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $7,653 | -3.5% | 5,586 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $7,932 | +5.2% | 5,586 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $7,541 | -22.4% | 5,586 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $9,720 | -4.9% | 5,586 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $10,222 | – | 5,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 50,232 | $34,000 | 0.00% |
| Renaissance Technologies | 1,269,326 | $850,000 | 0.00% |
| VANGUARD GROUP INC | 106,172 | $71,000 | 0.00% |
| UBS Group AG | 7,627 | $5,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 9 | $0 | 0.00% |
| NORTHERN TRUST CORP | 13,399 | $9,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 162,686 | $108,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,286 | $0 | 0.00% |
| BlackRock Inc. | 796 | $1,000 | 0.00% |